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TO THE EDITOR
Psoriasis is a common, chronic, inflam-
matory, organ-specific autoimmune
skin disease with a complex genetic
background (Nestle et al., 2009;
Zhang et al., 2013). Psoriasis vulgaris
(PsV) is the most common type,
accounting for approximately 85–90%
of all psoriasis patients, and character-
ized by raised, well-demarcated,
erythematous oval plaques with adher-
ent silvery scales (Nestle et al., 2009).
Generalized pustular psoriasis (GPP) is
the least prevalent form of psoriasis and
is considered to be a potentially life-
threatening, multi-systemic disease
(Ko¨rber et al., 2013), characterized by
the sudden eruption of generalized
sterile pustules in a wave-like manner
(Mengesha and Bennett, 2002).
Genetic factors have been shown to
have a critical role in the pathogenesis
of psoriasis, and several genes and
genomic regions have been reportedly
associated with some clinical forms of
this disease (http://omim.org/), includ-
ing the gene for caspase recruitment
domain family member 14 (CARD14),
which was identified by fine-mapping
of psoriasis susceptibility locus 2
(PSORS2) in European and Taiwanese
patients (Hwu et al., 2005; Jordan et al.,
2012a). To date, 23 variants have
been reported in the CARD14 gene
(Supplementary Table S3 online),
mainly in patients with PsV (Jordan
et al., 2012a; 2012b; Ko¨rber et al.,
2013). However, most studies of
CARD14 have been carried out in
European populations, and studies in
Chinese patients are rare.
We performed direct DNA sequen-
cing in 236 psoriasis patients (174 PsV
and 62 GPP patients) and 365 controls
to investigate the prevalence of
CARD14 variants in the Chinese Han
population. We also compared
CARD14 variants between patients with
GPP and PsV and between pediatric-
and late-onset PsV.
A total of four new, rare heterozygous
missense variants (allele frequency
o1%) were found in the CARD14
exon, all with frequencies of 0.2%
in psoriasis patients: p.Met119Val
(c.355A4G) and p.Arg166His (c.497G
4A) were only seen in GPP with PsV
patients, and p.Ala216Thr (c.646G4A)
and p.Thr591Met (c.1772C4T)
(rs200102454) were only seen in PsV
patients. We predicted the effects of the
four variants on protein function using
the Sorting Intolerant From Tolerant
(SIFT) tool (http://sift.bii.a-star.edu.sg).
Only p.Thr591Met was predicted to
have damaging effects (score¼ 0.03),
whereas the other three were pre-
dicted to be tolerated (Supplementary
Table S4 and Supplementary Figure S1
online).
An additional known rare heterozy-
gous variant p.Arg682Trp (c.2044C4T)
(rs117918077), which was reported
in 1.3% of 2169 European psoriasis
patients (Jordan et al., 2012b), was
only found in one GPP with PsV
patient (0.2% in psoriasis patients) in
this study (Supplementary Table S4 and
Supplementary Figure S1 online).
The overall frequency of these five
rare variants was 1.1% in psoriasis
patients (0.6% in PsV patients and
2.4% in GPP patients) but 0% in con-
trols. A significant association between
CARD14 rare variants and GPP was
observed using Fisher’s exact test (cor-
rected-P¼0.03), but there was no sig-
nificant association with either psoriasis
or PsV (corrected-P¼ 0.09, 0.998,
respectively). We also conducted a
gene-burden test using the sequence
kernel association test package to com-
pare the distributions of the five rare
missense variants in psoriasis patients
and controls, which showed a P-value
of 0.00172. Subtype analysis of PsV
versus GPP and pediatric- versus
late-onset PsV revealed no significant
differences in the frequencies of the five
rare variants (corrected-P¼0.438, 1,
respectively; Table 1).
One known low-frequency variant,
p.Asp176His (c.526G4C) (rs144475004),
was detected with frequencies of 1.9%
in psoriasis patients and 1.8% in con-
trols. Three common single-nucleotide
polymorphisms (SNPs), rs2066964,
rs34367357, and rs11652075, were also
detected in our samples, with frequen-
cies of 44.1 vs. 7.4 vs. 44.3% in psor-
iasis patients and 46.0 vs. 5.6 vs. 48.2%
in controls, respectively. There were no
differences between the groups in terms
of these four variants (Supplementary
Table S5 and Supplementary Figure S1
online).
CARD14 is located within PSORS2
and encodes a nuclear factor (NF)-kB
activator. Variants in CARD14 have
recently been detected in association
with psoriasis, mostly in patients
with PsV (Jordan et al., 2012b). Parti-
cular rare variants within CARD14
could lead to psoriasis by upregu-
lating psoriasis-associated genes in
keratinocytes (Jordan et al., 2012a).
The present study identified five rare
variants that, in combination, were
more common in psoriasis patientsAccepted article preview online 7 July 2014; published online 7 August 2014
Abbreviations: CARD14, caspase recruitment domain family member 14; GPP, generalized pustular
psoriasis; late-onset PsV, late-onset psoriasis vulgaris; pediatric-onset PsV, pediatric-onset psoriasis vulgaris;
PsV, psoriasis vulgaris
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compared with controls. Regarding the
predicted effects of these rare variants
on protein function, p.Thr591Met and
p.Arg682Trp were predicted to be
damaging, possibly by regulating the
activation of NF-kB, leading to inflam-
mation and epidermal hyperplasia. The
other variants were not predicted to be
damaging, and their functions remain
unknown.
GPP is considered to differ from PsV
in terms of its etiology, especially
regarding variants in the IL36RN gene
(Ko¨rber et al., 2013; Li et al., 2013;
Sugiura et al., 2013). In our study,
variants within CARD14 significantly
associated with GPP, compared with
controls. However, we failed to find
any difference between GPP and PsV,
which might be attributed to the
insufficient sample size. To elucidate
whether the gene CARD14 is a specific
susceptibility gene for PsV or GPP,
further study with a large sample size
is needed.
Different genes have been reported to
be responsible for diseases with different
onset ages (Swanbeck et al., 1995).
Cheng et al. (2014) performed an
association analysis in patients with
early-onset psoriasis (onset age o40
years) and identified significant
associations with the SNP rs4649203
in IL28RA and rs2303138 in LNPEP
(rs4649203, P¼ 0.0191, odds ratio
(OR)¼ 0.87; rs2303138, P¼ 0.00391,
OR¼1.15). However, the current
study failed to distinguish between
pediatric- and late-onset PsV in terms
of CARD14 variants. We therefore
conclude that the CARD14 gene
variant cannot explain age of onset in
this cohort of psoriasis patients.
In conclusion, we performed an
association analysis between CARD14
variants and psoriasis in a Chinese
Han population. The results suggest
that rare CARD14 variants may have
an important role in the pathogenesis of
GPP.
This study was approved by the
human medical and ethics committee
of Shandong Provincial Institute of Der-
matology and Venereology and was
conducted according to the Declaration
of Helsinki Principles. After informed
consent, genomic DNA was extracted
from patients’ peripheral blood samples
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using a QuickGene DNA whole blood
kit L (Kurabo Industries, Osaka, Japan).
All exons of the CARD14 gene were
amplified by PCR, and the products
were sequenced on an ABI 3130xl
Genetic Analyser (Applied Biosystems
ABI, Carlsbad, CA). (For specific details
about materials and methods see
Supplementary Data online).
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An Actin-Binding Protein Espin Is a Growth Regulator
for Melanoma
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TO THE EDITOR
Effective therapies for melanoma are
limited despite the fact that the inci-
dence is increasing at a greater rate than
that of any other cancers (Chen et al.,
1996). Identification of key molecules
regulating growth, progression, and
metastasis in melanoma is essential to
provide novel therapeutic strategies.
We previously developed RET-transge-
nic mice of line 304/B6 carrying
oncogenic RET (RFP/RET) under regu-
lation of the metallothionein-I promoter
(RET-mice), in which skin melanoma
develops spontaneously (Kato et al.,
1998). As melanoma in RET-mice
histopathologically resembles human
melanoma, RET-mice have been used
worldwide as a standard model for
melanoma (Kato et al., 1998;
Kumasaka et al., 2010).
The Espin gene encodes an actin
filament–binding protein (Bartles et al.,
1996; Sekerkova´ et al., 2006). Espin
affects the actin cytoskeleton, resulting
in a special association with micro-
villar specializations of sensory cells
(Sekerkova´ et al., 2004). Our recent
study showed that Espin expressed in
melanoma cells in mice and humans
affects metastasis through the regulation
of invasion via lamellipodia formation
(Yanagishita et al., 2014). That was the
first report showing a correlation bet-
ween Espin and cancer cells. However,
there has been no study showing
whether Espin regulates the prolife-
ration of cancer cells. In this study, we
examined the effect of Espin on ancho-
rage-dependent and -independent
growth of melanoma cells.
Anti-Espin rabbit polyclonal antibody
(Yanagishita et al., 2014), murineAccepted article preview online 17 June 2014; published online 10 July 2014
Abbreviations: GFP, green fluorescent protein; RET-mice, RET-transgenic mice
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